Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy
Science Advances · 05.07.2024 · 10 (27)
DOI: 10.1126/sciadv.adm9071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.07.2024. Verfasst von Daniel Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Precision Medicine, Tumor Microenvironment. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, a disease with dismal overall survival. Advances in treatment are hindered by a lack of preclinical models. Here, we show how a personalized organotypic “avatar” created from resected tissue allows spatial and temporal reporting on a complete in situ tumor microenvironment and mirrors clinical responses. Our perfusion culture method extends tumor slice viability, maintaining stable tumor content, metabolism, stromal composition, and immune cell populations for 12 days. Using multiplexed immunofluorescence and spatial transcriptomics, we identify immune neighborhoods and potential for immunotherapy. We used avatars to assess the impact of a preclinically validated metabolic therapy and show recovery of stromal and immune phenotypes and tumor redifferentiation. To determine clinical relevance, we monitored avatar response to gemcitabine treatment and identify a patient avatar-predictable response from clinical follow-up. Thus, avatars provide valuable information for syngeneic testing of therapeutics and a truly personalized therapeutic assessment platform for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
- Medicines Discovery Catapult, Alderley Park SK10 4ZF, UK.
- NanoString Technologies Inc., Seattle, WA, USA.
- Department of HPB surgery, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7DQ, UK.
ORCID-Profile: Daniel Hughes, Simei Go, Zahir Soonawalla, Frances Willenbrock, Eric O'Neill
Zitieren
APA
Hughes, D., Evans, A., Go, S., Eyres, M., Pan, L., Mukherjee, S., Soonawalla, Z., Willenbrock, F., & O'Neill, E. (2024). Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy. Science Advances, 10(27). https://doi.org/10.1126/sciadv.adm9071
Vancouver
Hughes D, Evans A, Go S, Eyres M, Pan L, Mukherjee S, et al. Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy. Science Advances. 2024;10(27). doi:10.1126/sciadv.adm9071
BibTeX
@article{Hughes2024,
author = {Hughes, Daniel and Evans, Alice and Go, Simei and Eyres, Michael and Pan, Liuliu and Mukherjee, Somnath and Soonawalla, Zahir and Willenbrock, Frances and O'Neill, Eric},
title = {Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {27},
doi = {10.1126/sciadv.adm9071}
}
EUVIMED